Physician profile
Nancy K Lo
NPI 1558779843
$4,347.11
in general payments reported to CMS, 2019-2025
14 companies · $430 in 2025
The $430 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $172 · 2021: $456 · 2022: $1,258 · 2023: $1,039 · 2024: $756 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,197 · Entertainment: $27.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,197.46 |
| Entertainment | $27.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,729.70 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $920.87 | 2019-2025 | Precision 1, Dailies Total1, Total30 |
| Coopervision INC. | $358.87 | 2021-2024 | Myday Contact Lens, Misight Contact Lens |
| Bausch & Lomb Americas INC. | $246.11 | 2022-2025 | Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $239.28 | 2019-2021 | |
| Glaukos Corporation | $156.27 | 2022-2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Oyster Point Pharma, INC. | $142.84 | 2022-2023 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $125.00 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $122.79 | 2024 | Xdemvy |
| Abbvie INC. | $96.56 | 2022 | |
| Aerie Pharmaceuticals, INC. | $90.68 | 2019 | |
| Maculogix, INC. | $72.91 | 2021 | |
| Optos, INC. | $27.65 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Biotissue Holdings INC. | $17.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Lo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.